Matinas BioPharma Holdings (MTNB) Goodwill (2015 - 2024)
Matinas BioPharma Holdings (MTNB) posted quarterly Goodwill of $1.3 million for Q3 2024, little changed year-over-year from $1.3 million in Q4 2023, and little changed quarter-over-quarter from $1.3 million in Q2 2024.
Matinas BioPharma Holdings (MTNB) Goodwill (2015 - 2024) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Goodwill for 10 consecutive years, with $1.3 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Goodwill changed 0.0% year-over-year to $1.3 million; the TTM figure through Sep 2024 stood at $1.3 million (changed 0.0% YoY), while the FY2023 annual figure was $1.3 million, changed 0.0% from the prior year.
- Goodwill steadied at $1.3 million in Q3 2024 per MTNB's latest filing, from $1.3 million in the prior quarter.
- Across five years, Goodwill topped out at $1.3 million in Q1 2020 and bottomed at $1.3 million in Q4 2021.
- Historically, Goodwill has averaged $1.3 million across 5 years, with a median of $1.3 million in 2020.
- Annual changes were most pronounced in 2020 — Goodwill changed 0.0% — and 2021, when it declined 0.04%.
- Matinas BioPharma Holdings' Goodwill stood at $1.3 million in 2020, then declined by 0.04% to $1.3 million in 2021, then changed by 0.0% to $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024.
- Business Quant data shows MTNB's Goodwill at $1.3 million in Q3 2024, $1.3 million in Q2 2024, and $1.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 1.34 Mn |
| Mar 31, 2021 | 1.34 Mn |
| Dec 31, 2020 | 1.34 Mn |
| Sep 30, 2020 | 1.34 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 1.34 Mn |
| Dec 31, 2019 | 1.34 Mn |